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Quality of Life Questionnaires for all respiratory
diseases, every language and ethnic minorities.
Are alternatives available?
F. MADSEN
Department of Internal Medicine, University of Copenhagen at H:S Frederiksberg Hospital, Copenhagen, DenmarkQuality of life once was sought to be measured by
questionnaires and health economists, in their belief that
very complex feelings could be reduced to a constructed
number, the ‘Qualy’. We are now aware that quality of life
is dependent on many factors, of which health is only one.
Thus today, we prefer the expression ‘health-related’
quality of life, acknowledging the complexity of feelings.
Progress has been made in the field of ‘health-related
quality of life questionnaires’, especially in respiratory
medicine (1). Researchers, the pharmaceutical industry,
healthcare providers and clinicians now request methods
which make it possible to understand the complex
mechanisms underlying pharmacological, as well as non-
pharmacological, eects. It has become clear that many of
these mechanisms cannot be understood from physiological
measurements alone (2). As interest in ‘health-related
quality of life’ has increased during the last 10 years we
have been more often confronted with trials focusing on
improvements in this eect parameter, now recognized to
be extremely relevant. In respiratory medicine we have a
long tradition of using validated questionnaires only (3),
and careful reporting when exceptionally applying a non-
validated questionnaire (4). Papers from outside the English
spoken world often state ‘that a translated and validated
questionnaire was used’. At second thought one wonders,
what really constitutes a validated questionnaire? Before
answering that question let’s go back to the beginning of
the standardized questionnaires in respiratory medicine. By
means of these old and often highly standardized ques-
tionnaires, not always adequately translated, scientists have
produced invaluable information on respiratory diseases
and their prevention (5).
Forty years ago Sir Richard Fletcher published the
prototype of MRC questionnaire on respiratory disease (6).
The questionnaire was used in the classical London Postal
Survey. This cornerstone in epidemiology led to the
publication of a standard for conductors of epidemiological
surveys (7). In 1976 the MRC questionnaire was revised
and supplemented with training cassettes, for the inter-
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respiratory questionnaires began. Chronic bronchitis was
defined on the basis of the MRC questionnaire and the
definition was adopted world-wide (9). The degree of
standardization seemed to be high—the same questions
were used in many countries—allowing comparison of
disease prevalence and important findings, such as the
discovery of the harmful eects of tobacco smoke, to be
made on the basis of surveys using the MRC and ATS
questionnaires. Even though the questionnaires were care-
fully translated into dierent languages and assistance from
professional translators may have been obtained, we had no
guarantee that questions were conceptually understood in
the same way by dierent cultures, even with the same
language. This has been common knowledge in the social
and humanities sciences (10), but only for the last 10 years
has attention been drawn to this very important problem in
respiratory medicine (11). As an example the phrasing
‘wheeze’ does not exist in a Scandinavian population and
‘frustrated’ by asthma has too many sexual undertones in
the francophone world. The questionnaires, in their
primitive translations, have nevertheless contributed sig-
nificantly to the non-anglosaxon literature (12,13).
What then constitutes a validated questionnaire and do
alternatives exist? At present two alternatives are available.
One is to develop a new questionnaire, or have an existing
one translated, which in both cases are costly processes.
The other alternative is to rely on qualitative research
methods (14). However this may be as costly as the first
alternative if you are not trained in qualitative research.
What can be done at present, is to facilitate the high quality
conceptual translation process of already existing and
validated questionnaires—a costly process often only
possible by sponsoring from the industry.
Two main types of instrument are available: the general
(generic) questionnaire that measures general health pro-
files, such as the Medical Outcomes Survey Short Form 36
(SF 36) (15,16) and the disease-specific questionnaires, such
as the St. George respiratory questionnaire (17) and the
Juniper AQLQ (18). Today the SF-36 is the gold standard
for generic instruments due to the huge literature on
validation (10).
What then constitutes supreme quality in quality of life
questionnaires? Generally speaking, quality depends on the
degree of fulfilment of specified expectations (19). Com-
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the best performance from these instruments. In this
manner the quality-of-life measuring instruments do not
dier from physiological instruments, such as a spirometer
where only the best is good enough in trials and
epidemiology. In trials in asthma or pulmonary fibrosis,
we expect the instrument to record the disease-specific part
of quality of life and not the general health profile.
Applying both a generic and a disease-specific question-
naire allows us to control for changes in general health, a
potential confounder in studies looking for changes in
disease specific health related quality of life.
What then constitutes a validated questionnaire? If
evidence exists that the instrument measures what we have
specified it to measure then it is validated. At present we
cannot give a measurement of the validity of the instrument
unless we have a gold standard, which is only rarely the
case. When we do have a gold standard, as for example the
SF-36, then a new instrument can be compared with the
gold standard and the agreement between results will then
become a measure of criterion validity. When we do not
have a gold standard we have to construct a reference to
which we can compare our new instrument for several
parameters likely to reflect what we want to measure—and
thus we obtain the ‘construct validity’.
What then constitutes a good or maybe a high quality
questionnaire on life quality? Isn’t it sucient to have valid
questionnaires? The questionnaires also have to be reliable
and responsive. A reliable (reproducible) questionnaire
obtains the same results, within specified limits, from
repeated tests at dierent times and under dierent
conditions. The responsive questionnaire is able to show
changes in health-related quality of life, in other words it
should be sensitive to fluctuations in quality of life. Before
we can say we have a good or high quality questionnaire we
need to specify our expectations to the interpretability and
respondent burden, and if the questionnaire fulfils our
criteria on these two issues as well as on validity, reliability
and responsiveness we do have a high quality question-
naire.
Today we have at our disposal several fine instruments
which have been translated into several languages, and for
protocols where we need a disease-specific questionnaire it
seem reasonable to use an already validated specific
questionnaire together with the generic form.
The challenge we now face is how to deal with diseases
where no specific questionnaire has been published. Before
you begin to construct you own quality of life questionnaire
you should check out the non-profit MAPI database in
Lyon, to be certain that you have not overlooked an
already existing and translated quality of life questionnaire.
If negative, you are left with the choice of translating or
developing a new questionnaire which often will be
unrealistic due to lack of resources. What can be done is
to use the method applied by de Vries in this issue (20),
where health-related quality of life in a trial on pulmonary
fibrosis was explored. De Vries used the focus group
method, which is often cost-eective. An individual
qualitative interview may often be time consuming and
have no real benefit compared to the focus group. Combinethe focus group with a validated, reliable and responsive
generic questionnaire. The choice of a generic questionnaire
then seems to be simple if the SF-36 is available in your
language and culture.
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